[Endocrinopathy in the differential diagnosis of chronic fatigue syndrome].
Sterzl, I, Zamrazil, V · Vnitrni lekarstvi · 1996
Quick Summary
This review discusses how disorders of the endocrine system (hormone-producing glands) can cause fatigue and other symptoms that overlap with ME/CFS, making them difficult to distinguish. The authors highlight that some patients initially thought to have ME/CFS actually have treatable hormone conditions, particularly autoimmune thyroid disease or other glandular disorders. They also explore how problems with the stress-hormone system (the hypothalamus-pituitary-adrenal axis) might play a role in both endocrine disease and ME/CFS.
Why It Matters
This work highlights a critical clinical problem: patients with treatable endocrine disorders may be incorrectly diagnosed with ME/CFS and thus miss appropriate treatment. By emphasizing comprehensive endocrinological screening and exploring potential shared biological mechanisms (particularly HPA axis dysfunction), this paper helps clinicians avoid misdiagnosis and informs our understanding of ME/CFS pathophysiology.
Observed Findings
Fatigue and associated symptoms overlap between endocrinopathies and ME/CFS diagnostic criteria.
Some patients initially suspected of having CFS were found on investigation to have defined endocrinopathies.
Autoimmune endocrine conditions, including polyglandular autoimmune syndrome, require consideration in differential diagnosis.
Hypothalamic-pituitary-adrenal axis dysfunction may contribute to both endocrine and immune dysregulation.
Inferred Conclusions
Rigorous endocrinological evaluation is necessary in suspected ME/CFS cases to exclude treatable hormonal disorders.
Autoimmune endocrinopathies and CFS may share overlapping pathogenic mechanisms involving immune-endocrine interaction.
HPA axis dysfunction represents a potential convergence point for understanding both endocrine disease and ME/CFS pathophysiology.
Remaining Questions
What is the actual prevalence of misdiagnosed endocrine disease among patients clinically diagnosed with ME/CFS?
Which specific endocrine screening tests should be standard in ME/CFS diagnostic evaluation?
What are the precise mechanisms by which HPA axis dysfunction contributes to ME/CFS symptoms?
What This Study Does Not Prove
This editorial presents expert opinion and does not present new experimental data or patient cohort studies. It does not prove that HPA axis dysfunction causes ME/CFS, only that it may be involved in some cases. It cannot establish the prevalence of misdiagnosis or determine causative relationships between endocrine conditions and ME/CFS symptoms.